|
|
 |
 | Medical News Releases > News Topics > Medical Science >
Heart / Stroke
Heart disease is the leading cause of death in America, and stroke is third. Combined they kill nearly a million men and women in the United States each year. Another 64 million Americans live with cardiovascular disease. Researchers and doctors working in the Washington University Cardiovascular Division explore all options available to them as they combat these diseases. They interact freely with expert faculty in many other departments to discover new and effective treatments for all types of cardiovascular disease. The WUSTL cardiovascular faculty includes more than 200 highly respected members, including experts in virtually every cardio-related field of study.
Browse the articles and experts below for more information regarding heart disease and stroke.
| Faculty Experts: |
Showing Heart / Stroke Experts 1 through 5 of 12.
- Show More |
|
James G. Miller
Albert Gordon Hill Professor of Physics in Arts & Sciences
Professor Miller's research focuses on the physics of anisotropic, inherently inhomogeneous media. These systematic studies of the anisotropic properties of the heart have led to fundamentally new insights. In 1998 the National Institutes of Health grant supporting this research was awarded MERIT status, ...
Expertise: physics of anisotropic, inherently inhomogeneous media, anisotropic properties of the heart, diagnostic images of hearts, echocardiographic imagers
Direct contact: (314) 935-6229
/
james.g.miller@wustl.edu
|
Brian Gage
Associate professor of medicine
Gage is an internist and health service researcher. He specializes in two related fields: antithrombotic therapy and stroke prevention. He has developed a formula that can help predict the risk of stroke in patients with atrial fibrillation. These patients have a fivefold increased risk of stroke. ...
Expertise: antithrombotic therapy, stroke, atrial fibrillation
Media assistance: (314) 286-0111 / williamsdia@wustl.edu
|
Larry Taber
Professor of Biomedical Engineering
Taber has been probing the forces, stresses and deformations of the heart since the mid-1980s. A major focus of his work is to show that biomechanical forces may be as important as genetics in shaping the heart. Recently, Taber has developed a theory on tissue growth and morphogenesis--shape change--and ...
Expertise: biomechanics of cardiovascular development, heart, embryo, blood vessels
Direct contact: (314) 935-8544
/
lat@biomed.wustl.edu
|
Frank Yin
Stephen and Camilla Brauer Professor of Biomedical Engineering
Frank C. P. Yin, M.D., Ph.D., the Stephen and Camilla Brauer Professor of Biomedical Engineering and chair of the biomedical engineering department, is a world-renowned biomedical engineer. Yin heads a dynamic, young department, not yet five years old and already ranked among the top 20 in the nation. ...
Expertise: soft tissue mechanics, cell mechanics, hemodynamics
Direct contact: (314) 935-6164
/
yin@biomed.wustl.edu
|
Ralph Damiano Jr.
The John Shoenberg Professor of Surgery
 |
| Damiano |
The chief of cardiac surgery in the Division of Cariothoracic Surgery, Damiano is internationally recognized for his innovative research in surgical robotics and minimally invasive heart surgery.
Expertise: surgical robotics, minimally invasive heart surgery, robotically assisted surgery, minimally invasive surgery, heart rhythm abnormalities
Media assistance: (314) 286-0109 / reckessg@wustl.edu
|
Showing Heart / Stroke Experts 1 through 5 of 12.
- Show More |
|
| News Stories & Tip Sheets: |
Showing Heart / Stroke Stories 1 through 3 of 118.
- Show More |
|
Beta blocking
Many African-Americans have a gene that prolongs life after heart failure
April 20,
2008 -- About 40 percent of African-Americans have a genetic variant that can protect them after heart failure and prolong their lives, according to research conducted at the School of Medicine and collaborating institutions. The genetic variant has an effect that resembles that of beta blockers, drugs widely prescribed for heart failure. The new study offers a reason why beta blockers don't appear to benefit some African-Americans.
|
Avoiding vascular calcification
Readily available treatment could help prevent heart disease in kidney patients
April 17,
2008 -- The estimated 19 million Americans living with chronic kidney disease (CKD) face a high risk of death from cardiovascular disease, usually related to high levels of blood phosphate. Now researchers at the School of Medicine have demonstrated that high blood phosphate directly stimulates calcification of blood vessels and that phosphate-binding drugs can decrease vascular calcification.
|
Quiet killer
WUSM clinic devoted to treating deadly, silent heart condition
April 9,
2008 -- Every so often we read a news report in which a young athlete collapses and dies during a competition — it's rare, but it happens. And when it does, often the cause is a silent heart condition called hypertrophic cardiomyopathy (HCM). The Hypertrophic Cardiomyopathy Clinic at the School of Medicine is devoted to diagnosis and treatment of HCM.
|
Showing Heart / Stroke Stories 1 through 3 of 118.
- Show More |
|
Genes Explain Race Disparity in Response to a Heart Drug
The New York Times
and 5 others
April 29,
2008 -- Doctors who treat patients with heart failure have long been puzzled that many black patients seem to not respond to a class of drugs called beta blockers.
Now researchers at WUSTL and U. Maryland have found that these nonresponsive patients have a slightly altered version of a gene that muscles use to control responses to nerve signals.
The discovery raises questions about whom to treat with beta blockers and how to decide, researchers say. But, they add, its implications go beyond heart failure.
WUSTL cardiologist and principal investigator Gerald Dorn comments.
|
Cutting Phosphate May Protect Kidney Patients From Heart Trouble
The Washington Post
and 11 others
April 24,
2008 -- Readily available phosphate-binding drugs could help prevent heart disease in people with chronic kidney disease, a new study in the the Journal of the American Society of Nephrology finds.
WUSTL researchers led by pediatric nephrology specialist Keith Hruska and pediatrics instructor Suresh Mathew comment.
|
Reverse Your Risk
Good Housekeeping
April 1,
2008 -- WUSTL researcher Kathryn Diemer, clinical director of WUSTL's Bone Health Program, talks about bone-mineral density and other fracture risks in aging women.
|
Angioplasty's golden era may be fading
USA Today
and 1 others
March 27,
2008 -- Three major studies published in the past two years indicate that using the angioplasty to open blocked arteries to treat chest pain, or angina, may be riskier and no more beneficial than medication. WUSTL cardiologist Michael Rich comments on the study.
|
Latest thinking on avoiding heart disease
Chicago Tribune
Feb. 25,
2008 -- Connie Diekman, president of the American Dietetic Association and director of nutrition at WU comments on the latest recommendations on diet exercise and hearth health.
|
Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.
Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.
| |
|
| | |
|
Download
Show More Heart / Stroke Clips
Email this page
Print ready page